More importantly, SPINK1 enhanced the resistance of PCa cells to MIT, a DNA-targeting chemotherapeutic agent frequently used for human malignancies including PCa30,31 (Supplementary Fig. 4e). The gene discussed is SPINK1; the disease is posterior cortical atrophy.